News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
May, 2024
May 2024
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Neha Venkatesh: Expansive study on racial disparities in MDS
Photo from Neha Venkatesh/X
Apr 30, 2024, 02:48

Neha Venkatesh: Expansive study on racial disparities in MDS

Neha Venkatesh, Internal Medicine Resident at BCM IM Residency, shared on X/Twitter:

“Thankful to Sara Taveras Alam for letting me share this exciting, expansive study on racial disparities in MDS inpatient mortality outcomes at Binaytara Foundation, SCHD24 and Martha Mims for sharing this opportunity with me.”

Source: Neha Venkatesh/X

Binaytara Foundation cancer expansive study Martha Mims Neha Venkatesh OncoDaily Oncology racial disparities in MDS Sara Taveras Alam SCHD24 AMP
Blog
May 19, 2024, 06:54
Laura Vater: Clinic days can be draining because of....
Insight
May 19, 2024, 06:49
JeeSuk Chang: Our new Yonsei Cancer Center paper on 5fx ablative RT for primary breast tumors
Blog
May 19, 2024, 06:44
Tulsi Jose: Access to quality health care is a basic human right, not a luxury
Blog
May 19, 2024, 06:29
Aleix Prat: EVOMET Conference: ‘Deconstructing the evolution of metastasis’  
Insight
May 19, 2024, 06:05
Herbert Loong: Our latest recommendations for NTRK fusion testing and management in lung cancer
Insight
May 19, 2024, 05:52
Ahmed Abdelhakeem: Our meta-analysis on survival in stage IV gastric cancer patients with ovarian metastases
Insight
May 19, 2024, 05:46
Nancy Lin: Updated data for Pfizer cdk4-selective inhibitor PF-07220060
Blog
May 19, 2024, 05:46
Edward Christopher Dee: We highlight success stories in global oncology
Blog
May 19, 2024, 05:39
Christopher R. Friese will become University of Michigan’s next vice provost for academic and faculty affairs
Blog
May 19, 2024, 05:29
Eric Singhi: With FLAURAishing new frontline combination therapies for EGFR and metastatic NSCLC yet incomplete data
Blog
May 19, 2024, 05:13
Estela Rodriguez: Join us for this Panel Discussion on Careers in Oncology Academia during ASCO24
Drugs
May 19, 2024, 05:07
First prospective phase 2 study to directly compare two anti-PD-1 antibodies as first-line treatment in advanced NSCLC - Top Science